Simon Couillard(@simcouillard) 's Twitter Profileg
Simon Couillard

@simcouillard

Québec Lung Association Chair of Respiratory Research, Université de Sherbrooke • Asthma researcher, Canadian respirologist, Oxford graduate • Opinions my own.

ID:772665216

linkhttps://orcid.org/0000-0002-4057-6886 calendar_today22-08-2012 01:53:20

648 Tweets

363 Followers

250 Following

Chrystia Freeland(@cafreeland) 's Twitter Profile Photo

Nous assurons l'avenir de la recherche et de l'innovation de pointe au Canada en investissant dans les jeunes générations, dans les étudiants, chercheurs et innovateurs canadiens afin de favoriser la croissance économique et la productivité pour les générations à venir.

Nous assurons l'avenir de la recherche et de l'innovation de pointe au Canada en investissant dans les jeunes générations, dans les étudiants, chercheurs et innovateurs canadiens afin de favoriser la croissance économique et la productivité pour les générations à venir.
account_circle
Simon Couillard(@simcouillard) 's Twitter Profile Photo

Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study
thorax.bmj.com/content/early/…

account_circle
ThoraxBMJ(@ThoraxBMJ) 's Twitter Profile Photo

Editorial - Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist
Simon Couillard thorax.bmj.com/content/79/4/2…

account_circle
Simon Couillard(@simcouillard) 's Twitter Profile Photo

Delighted to have participated in this podcast with PeerVoice. 'Improving Outcomes in Severe Eosinophilic Asthma: Translating Recent Evidence With Biologics Into Patient Care'.
ca.peervoice.com/240201142/2402…

account_circle
NEJM(@NEJM) 's Twitter Profile Photo

Presented today at : MANDARA phase 3 trial

In this randomized trial, benralizumab was noninferior to mepolizumab for the induction of remission in patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis.

Full study: nej.md/3UNOmeS

Presented today at #AAAAI24: MANDARA phase 3 trial In this randomized trial, benralizumab was noninferior to mepolizumab for the induction of remission in patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis. Full study: nej.md/3UNOmeS
account_circle
Simon Couillard(@simcouillard) 's Twitter Profile Photo

It was a pleasure to write this editorial with Carlos Andrés Celis-Preciado .
Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist
doi.org/10.1136/thorax…
ThoraxBMJ

It was a pleasure to write this editorial with @pulmonology101 . Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist doi.org/10.1136/thorax… @ThoraxBMJ
account_circle
Simon Couillard(@simcouillard) 's Twitter Profile Photo

Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with Asthma doi.org/10.1164/rccm.2…

account_circle
Simon Couillard(@simcouillard) 's Twitter Profile Photo

Québec's updated asthma guidelines are unique because we clearly state the Blood eosinophil count >=0.3x10^9/L is a cardinal risk factor for severe asthma attacks in childen and adults.
vimeo.com/906596155

account_circle
Simon Couillard(@simcouillard) 's Twitter Profile Photo

Come join an exciting project!
A paediatric ORACLE.

l’oracle pédiatrique ..
 
event.fourwaves.com/fr/recrutement…

account_circle
Simon Couillard(@simcouillard) 's Twitter Profile Photo

Type-2 inflammation and lung function decline in chronic airway disease in the general population thorax.bmj.com/content/early/…

account_circle